<form id="hlx9v"><form id="hlx9v"><th id="hlx9v"></th></form></form>
      <form id="hlx9v"></form>
        <form id="hlx9v"></form>

        About us

        Maxhealth Medical Group China (herein after called Maxhealth) (NEEQ: 836163) is a leading platform for R&D (research and development), production and commercialization of medical technology in China. Based on the unsatisfied real clinical needs, Maxhealth integrates the cutting-edge clinical science, continuously promotes technological progress, improves diagnosis and treatment, and helps patients through transnational innovative R&D.
        We have cooperated with a number of global medical innovation institutions and top 500 pharmaceutical companies in R&D, production, market access, academy and product marketing in the Chinese market, and successfully established a link between Chinese and foreign medical technology R&D.
        Maxhealth was founded in Wuxi in 2009, with. It has subsidiaries andor offices in Shanghai, Beijing, Hong Kong, London, Tokyo, Auckland and other places. The product portfolio will continue to expand with a focus on the areas of Gastroenterology, Neuro-rehabilitation and Women Health.The company pays special attention to digestion, women's health, nerve rehabilitation and other fields.


        Maxhealth Medical Group Chin participated in the 84th CMEF China international medical device (spring) Exhibition

        READ MORE
        Maxhealth Medical Group China will will present pepsest salivary pepsin test reagent in 2020, GERD branch of China Association for international exchange of medical and health care

        On December 25, 2020, the 2020 annual meeting of gastroesophageal reflux disease branch of China Association for the promotion of ...
        READ MORE
        Report of the Symposium on

        With the change of dietary structure and living habits in China, the incidence rate of Chinese gastroesophageal reflux disease is ...
        READ MORE
        Xu Bin, director of the provincial clinical inspection center, and his party visited the company for guidanc

        On September 8, 2020, Professor Xu Bin, director of Jiangsu Clinical Laboratory Center and Zou Rongliang, director of Wuxi clinica...
        READ MORE


        Ͷע <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <֩>| <ı> <ı> <ı> <ı> <ı> <ı>